LYTIR

Insider · SEC Form 4 · Director

Jean J. Bienaime

Filed with the SEC as BIENAIME JEAN JACQUES; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: bought $524K of ASND, KROS. Filed a median of 2 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $524K in total; Insider sales: $0 in total.Jun: Insider purchases $10KJul: Insider purchases $11KAug: Insider purchases $503KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $524KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. KROSBought: Keros Therapeutics, Inc. Aug 17, 2026 1,000 shares filed Aug 19, 2026 19,592 shares held directly after, as filed 10b5-1 plan filing $10K
  2. ASNDBought: Ascendis Pharma A/S Aug 14, 2026 2,000 shares filed Aug 18, 2026 2 transactions filing $493K
  3. KROSBought: Keros Therapeutics, Inc. Jul 15, 2026 1,000 shares filed Jul 17, 2026 18,592 shares held directly after, as filed 10b5-1 plan filing $11K
  4. KROSBought: Keros Therapeutics, Inc. Jun 15, 2026 1,000 shares filed Jun 17, 2026 17,592 shares held directly after, as filed 10b5-1 plan filing $10K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • INCY: grant or award (code A), 1 entry, Jun 8, 2026
Code A
A grant or award from the company, such as stock given as pay.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.